Gardasil, the FDA, and VAERS: How Americans concerned about vaccines interact with government
Emily Tarsell thought she had enough information about Gardasil — a new vaccine marketed to young women to prevent certain types of cervical cancer — when she agreed to have her daughter receive the vaccine. But after her third and last injection of Gardasil, in 2008, Christina Tarsell, a previously healthy 21-year old, was dead.
The depth of this family’s anguish at the death of their daughter can’t be conveyed. But after some time (more…)